We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNL icon
751
Travel + Leisure Co
TNL
$4.68B
$213K ﹤0.01%
+5,252
New +$221K
GOOD
752
Gladstone Commercial Corp
GOOD
$627M
$208K ﹤0.01%
+10,020
New +$202K
VV icon
753
Vanguard Large-Cap ETF
VV
$51.9B
$206K ﹤0.01%
+1,590
New +$199K
IBN icon
754
ICICI Bank
IBN
$107B
$193K ﹤0.01%
16,800
-2,450
-13% -$25.5K
SPWR
755
DELISTED
SunPower Corporation Common Stock
SPWR
$181K ﹤0.01%
+42,435
New +$165K
LTM
756
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$179K ﹤0.01%
16,880
– –
AMX icon
757
America Movil
AMX
$77.1B
$177K ﹤0.01%
12,420
-1,150
-8% -$17.4K
ABEV icon
758
Ambev
ABEV
$47.4B
$167K ﹤0.01%
38,730
– –
CHMA
759
DELISTED
Chiasma, Inc. Common Stock
CHMA
$122K ﹤0.01%
23,500
– –
APHA
760
DELISTED
Aphria Inc. Common Shares
APHA
$103K ﹤0.01%
11,000
– –
INSY
761
DELISTED
Insys Therapeutics, Inc.
INSY
$85K ﹤0.01%
+18,500
New +$87.6K
GFI icon
762
Gold Fields
GFI
$29.4B
$83K ﹤0.01%
22,122
– –
BLDP
763
Ballard Power Systems
BLDP
$865M
$33K ﹤0.01%
+11,000
New +$36K
TTPH
764
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$21K ﹤0.01%
781
– –
ACAD icon
765
Acadia Pharmaceuticals
ACAD
$4.35B
– –
-173,700
Closed -$2.81M
ACB
766
Aurora Cannabis
ACB
$170M
– –
-103
Closed -$62K
AES icon
767
AES
AES
$10.6B
– –
-92,443
Closed -$1.34M
AGI icon
768
Alamos Gold
AGI
$12.5B
– –
-115,492
Closed -$416K
AOS icon
769
A.O. Smith
AOS
$8.61B
– –
-7,086
Closed -$303K
AVA icon
770
Avista
AVA
$3.43B
– –
-122,700
Closed -$5.21M
AVDL
771
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-62,000
Closed -$160K
BUD icon
772
AB InBev
BUD
$156B
– –
-4,500
Closed -$296K
DTE icon
773
DTE Energy
DTE
$30.6B
– –
-5,875
Closed -$551K
E icon
774
ENI
E
$73.5B
– –
-31
Closed -$1K
EC icon
775
Ecopetrol
EC
$32.5B
– –
-74,000
Closed -$1.18M
29 30
31
32 33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.